613 related articles for article (PubMed ID: 28477722)
1. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
Chipps BE; Lanier B; Milgrom H; Deschildre A; Hedlin G; Szefler SJ; Kattan M; Kianifard F; Ortiz B; Haselkorn T; Iqbal A; Rosén K; Trzaskoma B; Busse WW
J Allergy Clin Immunol; 2017 May; 139(5):1431-1444. PubMed ID: 28477722
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
Chipps BE; Figliomeni M; Spector S
Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
[TBL] [Abstract][Full Text] [Related]
3. The discovery and development of omalizumab for the treatment of asthma.
Licari A; Marseglia G; Castagnoli R; Marseglia A; Ciprandi G
Expert Opin Drug Discov; 2015; 10(9):1033-42. PubMed ID: 25979110
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
Tortajada-Girbés M; Bousquet R; Bosque M; Carrera Martínez JJ; Ibáñez MD; Moreira A; Nieto A; Plaza AM; Rivas C; Requena G; Sánchez-Solis M; Tabar A; Torres-Borrego J; Zapatero L
Expert Rev Respir Med; 2018 Sep; 12(9):745-754. PubMed ID: 30141696
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
Odajima H; Ebisawa M; Nagakura T; Fujisawa T; Akasawa A; Ito K; Doi S; Yamaguchi K; Katsunuma T; Kurihara K; Kondo N; Sugai K; Nambu M; Hoshioka A; Yoshihara S; Sato N; Seko N; Nishima S
Allergol Int; 2015 Oct; 64(4):364-70. PubMed ID: 26433533
[TBL] [Abstract][Full Text] [Related]
6. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab in asthma: an update on recent developments.
Humbert M; Busse W; Hanania NA; Lowe PJ; Canvin J; Erpenbeck VJ; Holgate S
J Allergy Clin Immunol Pract; 2014; 2(5):525-36.e1. PubMed ID: 25213045
[TBL] [Abstract][Full Text] [Related]
8. The use of anti-IgE therapy beyond allergic asthma.
Stokes JR; Casale TB
J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
Corren J; Kavati A; Ortiz B; Colby JA; Ruiz K; Maiese BA; Cadarette SM; Panettieri RA
Allergy Asthma Proc; 2017 Jul; 38(4):250-263. PubMed ID: 28631599
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma.
Luu M; Bardou M; Bonniaud P; Goirand F
Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1503-1511. PubMed ID: 27748630
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the total IgE level by omalizumab in children and adolescents.
Steiss JO; Strohner P; Zimmer KP; Lindemann H
J Asthma; 2008 Apr; 45(3):233-6. PubMed ID: 18415832
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in moderate-to-severe allergic asthmatics treated with omalizumab: a systematic literature review of randomized controlled trials.
Corren J; Kavati A; Ortiz B; Vegesna A; Colby JA; Ruiz K; Panettieri RA
Curr Med Res Opin; 2018 Jan; 34(1):65-80. PubMed ID: 29057669
[TBL] [Abstract][Full Text] [Related]
16. [Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia].
Morales-Múnera O; Pedraza Á; Niño-Serna L
Rev Alerg Mex; 2018; 65(3):222-232. PubMed ID: 30176200
[TBL] [Abstract][Full Text] [Related]
17. Novel targets of omalizumab in asthma.
Sattler C; Garcia G; Humbert M
Curr Opin Pulm Med; 2017 Jan; 23(1):56-61. PubMed ID: 27798419
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab therapy for children and adolescents with severe allergic asthma.
Romano C
Expert Rev Clin Immunol; 2015; 11(12):1309-19. PubMed ID: 26312385
[TBL] [Abstract][Full Text] [Related]
19. Four-year follow-up in children with moderate/severe uncontrolled asthma after withdrawal of a 1-year omalizumab treatment.
Baena-Cagnani CE; Teijeiro A; Canonica GW
Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):267-71. PubMed ID: 25899697
[TBL] [Abstract][Full Text] [Related]
20. A review of omalizumab for the management of severe asthma.
Lin CH; Cheng SL
Drug Des Devel Ther; 2016; 10():2369-78. PubMed ID: 27528798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]